Article
Genetically engineered mouse models of prostate cancer.
Molecular oncology - 1 Apr 2013
Parisotto Maxime, Metzger Daniel
Abstract excerpt
Despite major improvement in treatment of early stage localised prostate cancer, the distinction between indolent tumors and those that will become aggressive, as well as the lack of efficient therapies of advanced prostate cancer, remain major health problems. Genetically engineered mice (GEM) have been extensively used to investigate the molecular and cellular mechanisms underlying prostate tumor initiation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
